Fig 1.
Participant flow diagram.
Table 1.
Comparison of target population to analytic sample; and characteristics of children and young people in analytic sample by baseline PCR-test result: N (%).
Fig 2.
Symptoms with overall prevalence increasing from baseline to 3 months and increasing or remaining high at 6 months.
Fig 3.
Symptoms with overall prevalence declining from baseline to 6 months post-test in test-positives*.
Fig 4.
Symptoms with low overall prevalence (less than 10%) at baseline.
Table 2.
Prevalence N (%) of CYP who had a symptom (never, once, twice or thrice) at testing, at 3 months post-test, at 6 months post-test.
Table 3.
Difference in prevalence of shortness of breath, tiredness and dizziness at 6 months post-test, between test-positives and test-negatives, by time symptom first reported.